Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SDE for post-hemorrhoidectomy pain
NCT02468128Phase 3Completed
- Sponsor
- Lumosa Therapeutics
- Start
- Dec 2012
- Primary completion
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dinalbuphine sebacate in pain, sponsored by Lumosa Therapeutics. Started Dec 2012; status: completed.
02
Drugs
dinalbuphine sebacate
03
Conditions
pain
Beyond the preview
Go deeper on NCT02468128.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02468128.